Study on Antituberculous Antibody in Hemodialysis Patients
Study on urinary ATP concentration and its clinical significance
論文 (134件)：
Kazuhiro Ishikawa, Ryo Hasegawa, Keitaro Furukawa, Fujimi Kawai, Yuki Uehara, Kiyofumi Ohkusu, Nobuyoshi Mori. Recurrent Bacillus subtilis Var. Natto Bacteremia and Review of the Literature on Bacillus subtilis: The First Case Report. The American journal of case reports. 2024. 25. e942553
Takeshi Arashiro, Yuzo Arima, Jin Kuramochi, Hirokazu Muraoka, Akihiro Sato, Kumi Chubachi, Kunihiro Oba, Atsushi Yanai, Hiroko Arioka, Yuki Uehara, et al. Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan. Vaccine. 2023
Kazuhiro Ishikawa, Ryo Hasegawa, Koko Shibutani, Yumiko Mikami, Fujimi Kawai, Takahiro Matsuo, Yuki Uehara, Nobuyoshi Mori. Probiotic-related Clostridium butyricum bacteremia: A case report and literature review. Anaerobe. 2023. 83. 102770-102770
Koh Shinohara, Yuki Uehara, Katsuji Teruya, Takashi Sasaki, Tadashi Baba, Hidemasa Nakaminami, Pegah Kananizadeh, Yuh Morimoto, Yoshimi Kikuchi, Shinichi Oka. Emergence of community-associated methicillin-resistant Staphylococcus aureus ΨUSA300 among Japanese people with HIV, resulted from stepwise mutations in 2010s. Scientific reports. 2023. 13. 1. 8322-8322
Takeshi Arashiro, Yuzo Arima, Jin Kuramochi, Hirokazu Muraoka, Akihiro Sato, Kumi Chubachi, Atsushi Yanai, Hiroko Arioka, Yuki Uehara, Genei Ihara, et al. Effectiveness of BA.1- and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines against symptomatic SARS-CoV-2 infection during the BA.5-dominant period in Japan. Open Forum Infectious Diseases. 2023
